1. Clinical and Prognostic Features in a Series of 277 Patients with Chronic Myelomonocytic Leukemia (CMML) from South America: A Multicenter Study. (April 2017) Authors: Gonzalez, J.S.; Bestach, Y.; Arbelbide, J.; Perusini, A.; Romagnoli, C.; Fantl, D.; De Dios Soler, M.; Rossenhain, M.; Santos, I.; Lima, W. Macedo; Velloso, E.; Rocha, V.; Larripa, I.; Flores, M.G.; Belli, C. Journal: Leukemia research Issue: Volume 55(2017)Supplement 1 Page Start: S141 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P764: RESPONSE AND SURVIVAL OUTCOMES WITH HYPOMETHYLATING AGENTS IN AN ARGENTINEAN COHORT OF 113 PATIENTS WITH CHRONIC MYELOMONOCITIC LEUKEMIA. (23rd June 2022) Authors: Gonzalez, J.; Perusini, A.; Russo, F.; Fuentes, L.; Deluca, T.; Basquiera, A. L.; Navickas, A.; Kornblihtt, L.; Pintos, N.; Nucifora, E.; Iastrebner, M.; Enrico, A.; Arbelbide, J.; Belli, C. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 659 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Topic: AS03-Health Economics & Outcome Research/AS03a-Cost of care: ALTERNATIVE DOSING SCHEDULES OF AZACITIDINE: A REAL-WORLD COMPARATIVE STUDY ACROSS SOUTH AMERICAN CENTERS. (May 2023) Authors: Castelo, L.; Belli, C.; Buccheri, V.; Perusini, A.; Enrico, A.; Arbelbide, J.; Silva, W.; Iastrebner, M.; Gonzalez, J.; Pereyra, P.; Pereira, T.; Marchi, L.; Rocha, V.; Velloso, E. Journal: Leukemia research Issue: Volume 128(2023)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗